Tag: oral solid dosage contract manufacturing market size

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Oral Solid Dosage Contract Manufacturing Market Value Expansion And Long-Term Growth Outlook

The market for contract manufacturing of oral solid dosage forms has experienced robust expansion lately, with projections indicating a rise from $42.39 billion in 2025 to $45.59 billion by 2026, reflecting a compound annual growth rate of 7.6%. This growth trajectory during the preceding period was influenced by several key factors, including heightened efforts to curb internal production expenses, the escalating intricacy of oral solid dosage drug formulations, a surge in the output of generic medications, constraints on the manufacturing capabilities of pharmaceutical firms, and an increasing dependency on external contract manufacturing organizations.

The marketplace for the contract manufacturing of oral solid pharmaceutical forms is poised for significant expansion in the upcoming years, projecting a rise to $59.05 billion by 2030, driven by a compound annual growth rate of 6.7%. This predicted upswing is underpinned by several key factors: an escalating need for adaptable and scalable pharmaceutical production processes, a widening array of new oral solid drug candidates in development pipelines, increased financial commitment to sophisticated manufacturing technologies, the broader adoption of pharmaceutical outsourcing practices in developing economies, and a heightened requirement for adaptable and swift production capacities. Dominant currents shaping this sector throughout the projected period encompass a greater tendency for pharmaceutical firms to delegate the manufacturing of oral solid dosage forms, a surge in the requirement for producing tablets and capsules in large quantities at competitive price points, a growing embrace of oral solid dosage formulations featuring modified and sustained release mechanisms, an intensified emphasis on adhering to regulatory standards and ensuring robust quality assurance within contract manufacturing operations, and a growing inclination towards comprehensive manufacturing and packaging solutions that cover the entire production lifecycle.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Oral Solid Dosage Contract Manufacturing Market Growth Factors Supporting Long-Term Expansion

The expanding appetite for generic medications is anticipated to be a primary catalyst for the advancement of the contract manufacturing sector focused on oral solid dosage forms. Generic drugs, recognized for their sameness to branded counterparts in terms of dosage, potency, safety, effectiveness, quality, and intended application, are seeing increased uptake due to factors such as expiring patents, the imperative for cost reduction, supportive regulatory policies, and broader access to healthcare services. Contract manufacturers specializing in oral solid dosage forms play a crucial role in facilitating the creation and dissemination of these generic medicines, offering expertise that boosts operational effectiveness, curtails expenses, guarantees superior product quality, and accelerates market entry. Illustrating this trend, the U.S. Food and Drug Administration noted in 2025 that it had sanctioned over 35,000 distinct generic drugs, with statistics indicating that nine out of every ten prescriptions are fulfilled using generic options. Additionally, the FDA’s proactive approach in November 2024 led to the issuance of more than 800 updated Product-Specific Guidances (PSGs) tailored for immediate-release solid oral generic drug products, further underscoring the supportive environment for generics and consequently fueling the expansion of the oral solid dosage contract manufacturing market.

Oral Solid Dosage Contract Manufacturing Market Segment Outlook: Which Categories Are Expanding The Fastest?

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

Oral Solid Dosage Contract Manufacturing Market Industry Trends Shaping Future Revenue Growth

Leading players within the oral solid dosage contract manufacturing sector are strategically investing in pioneering advancements, exemplified by the implementation of continuous manufacturing lines, as a means to solidify their market standing. This approach entails establishing production environments or systems designed to employ continuous manufacturing methodologies for pharmaceutical and similar goods. As an illustration, by January 2023, WuXi STA, a pharmaceutical entity based in China, introduced its inaugural continuous manufacturing line specifically for oral solid pharmaceutical goods. This state-of-the-art facility represents a substantial leap forward in pharmaceutical production, harnessing the benefits of continuous manufacturing to boost the overall efficiency, quality standards, and adaptability inherent in drug production workflows, thereby enabling quicker project completion and minimizing operational interruptions, ultimately expediting the availability of essential medicines to those in need.

Oral Solid Dosage Contract Manufacturing Market Key Companies And Competitive Benchmarking

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Access The Complete Oral Solid Dosage Contract Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Oral Solid Dosage Contract Manufacturing Market Leading Geography: Which Region Generates The Most Revenue?

Asia-Pacificwas the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Rise In Market Size Of The Oral Solid Dosage Contract Manufacturing Market During The Forecast Period?

The oral solid dosage contract manufacturing market has shown significant expansion in recent years. Its value is predicted to increase from $42.39 billion in 2025 to $45.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The historical growth of this market can be attributed to several factors, such as the increasing need to reduce in-house manufacturing expenditures, the growing complexity of oral solid dosage formulations, rising volumes of generic drug production, restricted internal manufacturing capacity among pharmaceutical companies, and an increasing reliance on third-party Contract Manufacturing Organizations (CMOs).

The oral solid dosage contract manufacturing market size is projected to experience significant growth in the coming years. It is anticipated to expand to $59.05 billion in 2030, showing a compound annual growth rate (CAGR) of 6.7%. The expansion during the forecast period can be attributed to factors such as a growing demand for scalable pharmaceutical manufacturing solutions, an increasing pipeline of oral solid dosage drugs, rising investment in advanced manufacturing technologies, the expansion of pharmaceutical outsourcing in emerging markets, and a heightened need for flexible and rapid production capabilities. Key trends in the forecast period include an increasing tendency for pharmaceutical companies to outsource oral solid dosage manufacturing, a greater demand for high-volume and cost-efficient tablet and capsule production, the growing adoption of modified and controlled release oral solid dosage forms, an enhanced focus on regulatory compliance and quality assurance in contract manufacturing, and a rising preference for comprehensive end-to-end manufacturing and packaging services.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Strategic Drivers Are Supporting The Oral Solid Dosage Contract Manufacturing Market Development?

The escalating requirement for generic pharmaceuticals is projected to fuel the expansion of the oral solid dosage contract manufacturing market in the future. These drugs are medicines functionally identical to their brand-name counterparts concerning dosage, strength, safety, performance, quality, and their intended application. This heightened demand for generic medicines stems from factors such as patent expirations, initiatives to control costs, encouraging regulatory policies, and broader access to medical services. Oral solid dosage contract manufacturing plays a vital role in supporting the creation and delivery of generic drugs, utilizing the expertise of contract manufacturers to boost operational effectiveness, cut expenses, guarantee superior production quality, and facilitate faster, more efficient market entry for these products. As an illustration, in 2025, the Food and Drug Administration, a federal agency in the US, indicated that the FDA had approved over 35,000 generic drugs. Furthermore, 9 out of 10 prescriptions are dispensed as generic drugs. Additionally, in November of 2024, the FDA issued more than 800 updated Product-Specific Guidances (PSGs) for immediate-release solid oral generic drug products. Consequently, the increased need for generic drugs acts as a primary catalyst for the expansion of the oral solid dosage contract manufacturing market.

How Does Segment Analysis Break Down The Oral Solid Dosage Contract Manufacturing Market Structure?

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

What Trends Are Influencing The Oral Solid Dosage Contract Manufacturing Market Outlook?

Leading companies in the oral mucositis market are focusing on developing innovative solutions, such as cryotherapy, which employs cold therapy to minimize damage to oral tissues, thereby reducing the severity and incidence of the condition. Cryotherapy is a medical treatment that utilizes extreme cold to freeze and destroy abnormal or diseased tissue, applicable for conditions like warts, tumors, or injuries. For instance, in February 2024, Chemo Mouthpiece LLC, a US-based medical device company, announced the approval of its chemo mouthpiece device by the Food and Drug Administration, a US-based government agency. This chemo mouthpiece serves as an intraoral ice pack, delivering cryotherapy to the oral cavity of patients undergoing chemotherapy. It proactively manages and treats oral mucositis, a common and painful side effect of chemotherapy.

Which Companies Are Engaged In The Oral Solid Dosage Contract Manufacturing Market Environment?

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Access The Complete Oral Solid Dosage Contract Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Region Is The Primary Market For The Oral Solid Dosage Contract Manufacturing Market?

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Oral Solid Dosage Contract Manufacturing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company

Oral Care Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Dental Flap Surgery Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report

Mouthwash Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/mouthwash-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Oral Solid Dosage Contract Manufacturing Market During The Forecast Period?

The oral solid dosage contract manufacturing market has demonstrated substantial expansion in recent years. This market is set to increase from $42.39 billion in 2025 to $45.59 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.6%. Historically, this growth can be attributed to several factors including rising pressure to reduce in-house manufacturing costs, increasing complexity of oral solid dosage formulations, growing generic drug production volumes, limited internal manufacturing capacity of pharma companies, and increasing reliance on third-party CMOs.

The oral solid dosage contract manufacturing market is projected for significant expansion over the coming years, with its size expected to reach $59.05 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.7%. This growth trajectory is fueled by several factors, including the escalating demand for scalable pharmaceutical manufacturing solutions, a growing pipeline of oral solid dosage drugs, increased investment in advanced manufacturing technologies, the expansion of pharmaceutical outsourcing into emerging markets, and a heightened need for flexible and rapid production capabilities. Concurrently, major trends for the forecast period encompass pharmaceutical companies increasingly outsourcing oral solid dosage manufacturing, a greater demand for high-volume and cost-efficient tablet and capsule production, wider adoption of modified and controlled-release oral solid dosage forms, an elevated focus on regulatory compliance and quality assurance in contract manufacturing, and a rising preference for comprehensive end-to-end manufacturing and packaging services.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Important Drivers Are Guiding The Oral Solid Dosage Contract Manufacturing Market Growth?

The oral solid dosage contract manufacturing market is anticipated to expand due to the escalating demand for generic drugs. Generic drugs are pharmaceutical products that exhibit bioequivalence to their brand-name counterparts concerning dosage, strength, safety, performance, quality, and intended application. This rising demand for generic medications is driven by patent expirations, ongoing cost containment initiatives, regulatory incentives, and broader access to healthcare services. Oral solid dosage contract manufacturing plays a vital role in supporting the production and distribution of generic drugs by allowing contract manufacturers to boost their operational efficiency, decrease costs, guarantee high-quality manufacturing, and facilitate a quicker and more effective market entry for these products. For example, in 2025, the Food and Drug Administration, a US-based federal agency, reported that over 35,000 generic drugs had been approved by the FDA, with 9 out of 10 prescriptions being filled with generic drugs. Additionally, in November of 2024, the FDA issued more than 800 revised Product-Specific Guidances (PSGs) for immediate-release solid oral generic drug products. Thus, the growing demand for generic drugs is a significant force driving the growth of the oral solid dosage contract manufacturing market.

What Are The Key Segment Divisions In The Oral Solid Dosage Contract Manufacturing Market Segment Structure?

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

What Trends Are Influencing The Evolution Of The Oral Solid Dosage Contract Manufacturing Market?

Leading companies in the oral solid dosage contract manufacturing market are concentrating on developing inventive solutions, such as continuous manufacturing lines, to uphold their market presence. A continuous manufacturing line describes a production setup or system that employs continuous manufacturing processes for the creation of pharmaceuticals or other goods. For example, in January 2023, WuXi STA, a pharmaceutical company from China, introduced its inaugural continuous manufacturing line for oral solid pharmaceutical products. This innovative facility signifies a major stride in pharmaceutical production, harnessing continuous manufacturing principles to improve efficiency, quality, and adaptability in drug manufacturing processes. This flexibility optimizes production schedules and decreases downtime, thereby accelerating the delivery of crucial medications to patients.

Which Organizations Are Engaged In The Oral Solid Dosage Contract Manufacturing Market?

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Get The Full Oral Solid Dosage Contract Manufacturing Market Report:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Region Accounts For The Largest Portion Of The Oral Solid Dosage Contract Manufacturing Market?

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oral Solid Dosage Contract Manufacturing Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company

Oral Care Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Dental Flap Surgery Market Report

https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report

Mouthwash Market Report

https://www.thebusinessresearchcompany.com/report/mouthwash-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Oral Solid Dosage Contract Manufacturing Market During 2026–2030?

The oral solid dosage contract manufacturing market size has experienced strong growth in recent years. It is projected to expand from $42.39 billion in 2025 to $45.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed in the historic period can be attributed to factors such as increasing pressure to reduce in-house manufacturing costs, the rising complexity of oral solid dosage formulations, growing generic drug production volumes, limited internal manufacturing capacity of pharmaceutical companies, and an increasing reliance on third-party CMOs.

The oral solid dosage contract manufacturing market is projected to experience substantial expansion over the coming years. This market is forecast to reach $59.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. This anticipated growth is driven by several factors, including an escalating demand for scalable pharmaceutical production solutions, an expanding range of oral solid dosage drugs in development, increased investment in sophisticated manufacturing technologies, the broadening scope of pharmaceutical outsourcing in nascent markets, and a heightened requirement for agile and swift production capacities. Key trends expected during this period involve a surge in pharmaceutical companies’ outsourcing of oral solid dosage manufacturing, a greater need for large-volume and economical tablet and capsule manufacturing, the expanding use of modified and controlled-release oral solid dosage formulations, an intensified emphasis on regulatory adherence and quality assurance in contract manufacturing, and a rising inclination towards comprehensive manufacturing and packaging services.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Major Factors Are Driving The Expansion Of The Oral Solid Dosage Contract Manufacturing Market?

The future expansion of the oral solid dosage contract manufacturing market is anticipated, driven by the growing need for generic drugs. These medications mirror brand-name drugs across aspects like dosage, strength, safety, performance, quality, and their intended application. The increased appetite for generics stems from factors such as patents expiring, initiatives to control costs, encouraging regulations, and wider access to healthcare services. Oral solid dosage contract manufacturing plays a crucial role in the creation and supply of generic medicines, utilizing contract manufacturers’ expertise to boost efficiency, lower expenses, guarantee superior quality, and accelerate product launches. Illustratively, the Food and Drug Administration (FDA), a federal agency in the US, indicated that by 2025, more than 35,000 generic drugs received FDA approval, with 9 out of 10 prescriptions being for generics. Additionally, in November of 2024, the FDA issued over 800 updated Product-Specific Guidances (PSGs) for immediate-release solid oral generic drug products. Consequently, the sustained demand for generic drugs fuels the expansion of the oral solid dosage contract manufacturing market.

How Are The Various Segments Of The Oral Solid Dosage Contract Manufacturing Market Categorized?

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

Which Trends Are Impacting The Growth Of The Oral Solid Dosage Contract Manufacturing Market?

Leading firms within the oral solid dosage contract manufacturing market are prioritizing the creation of advanced solutions, like continuous manufacturing systems, to maintain their competitive edge. Such a line denotes a production setup or facility employing uninterrupted manufacturing techniques for pharmaceutical or other product fabrication. An example of this is seen in January 2023, when WuXi STA, a pharmaceutical firm based in China, unveiled its inaugural continuous manufacturing line specifically for oral solid pharmaceutical goods. This state-of-the-art facility represents a major leap forward in drug production, utilizing continuous manufacturing principles to boost the efficiency, quality, and adaptability of drug production methods. This flexibility helps optimize production schedules and minimize idle periods, thereby speeding up the provision of essential medicines to those in need.

Which Major Firms Influence Developments In The Oral Solid Dosage Contract Manufacturing Market?

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Read the full oral solid dosage contract manufacturing market report here:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Region Currently Holds The Largest Share Of The Oral Solid Dosage Contract Manufacturing Market?

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oral Solid Dosage Contract Manufacturing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company

Oral Care Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Dental Flap Surgery Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report

Mouthwash Global Market Report

https://www.thebusinessresearchcompany.com/report/mouthwash-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Oral Solid Dosage Contract Manufacturing Market During 2026–2030?

The oral solid dosage contract manufacturing market size has experienced strong growth in recent years. It is projected to expand from $42.39 billion in 2025 to $45.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed in the historic period can be attributed to factors such as increasing pressure to reduce in-house manufacturing costs, the rising complexity of oral solid dosage formulations, growing generic drug production volumes, limited internal manufacturing capacity of pharmaceutical companies, and an increasing reliance on third-party CMOs.

The oral solid dosage contract manufacturing market is projected to experience substantial expansion over the coming years. This market is forecast to reach $59.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. This anticipated growth is driven by several factors, including an escalating demand for scalable pharmaceutical production solutions, an expanding range of oral solid dosage drugs in development, increased investment in sophisticated manufacturing technologies, the broadening scope of pharmaceutical outsourcing in nascent markets, and a heightened requirement for agile and swift production capacities. Key trends expected during this period involve a surge in pharmaceutical companies’ outsourcing of oral solid dosage manufacturing, a greater need for large-volume and economical tablet and capsule manufacturing, the expanding use of modified and controlled-release oral solid dosage formulations, an intensified emphasis on regulatory adherence and quality assurance in contract manufacturing, and a rising inclination towards comprehensive manufacturing and packaging services.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Major Factors Are Driving The Expansion Of The Oral Solid Dosage Contract Manufacturing Market?

The future expansion of the oral solid dosage contract manufacturing market is anticipated, driven by the growing need for generic drugs. These medications mirror brand-name drugs across aspects like dosage, strength, safety, performance, quality, and their intended application. The increased appetite for generics stems from factors such as patents expiring, initiatives to control costs, encouraging regulations, and wider access to healthcare services. Oral solid dosage contract manufacturing plays a crucial role in the creation and supply of generic medicines, utilizing contract manufacturers’ expertise to boost efficiency, lower expenses, guarantee superior quality, and accelerate product launches. Illustratively, the Food and Drug Administration (FDA), a federal agency in the US, indicated that by 2025, more than 35,000 generic drugs received FDA approval, with 9 out of 10 prescriptions being for generics. Additionally, in November of 2024, the FDA issued over 800 updated Product-Specific Guidances (PSGs) for immediate-release solid oral generic drug products. Consequently, the sustained demand for generic drugs fuels the expansion of the oral solid dosage contract manufacturing market.

How Are The Various Segments Of The Oral Solid Dosage Contract Manufacturing Market Categorized?

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

Which Trends Are Impacting The Growth Of The Oral Solid Dosage Contract Manufacturing Market?

Leading firms within the oral solid dosage contract manufacturing market are prioritizing the creation of advanced solutions, like continuous manufacturing systems, to maintain their competitive edge. Such a line denotes a production setup or facility employing uninterrupted manufacturing techniques for pharmaceutical or other product fabrication. An example of this is seen in January 2023, when WuXi STA, a pharmaceutical firm based in China, unveiled its inaugural continuous manufacturing line specifically for oral solid pharmaceutical goods. This state-of-the-art facility represents a major leap forward in drug production, utilizing continuous manufacturing principles to boost the efficiency, quality, and adaptability of drug production methods. This flexibility helps optimize production schedules and minimize idle periods, thereby speeding up the provision of essential medicines to those in need.

Which Major Firms Influence Developments In The Oral Solid Dosage Contract Manufacturing Market?

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Read the full oral solid dosage contract manufacturing market report here:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Region Currently Holds The Largest Share Of The Oral Solid Dosage Contract Manufacturing Market?

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oral Solid Dosage Contract Manufacturing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company

Oral Care Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Dental Flap Surgery Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report

Mouthwash Global Market Report

https://www.thebusinessresearchcompany.com/report/mouthwash-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Oral Solid Dosage Contract Manufacturing Market During 2026–2030?

The oral solid dosage contract manufacturing market size has experienced strong growth in recent years. It is projected to expand from $42.39 billion in 2025 to $45.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed in the historic period can be attributed to factors such as increasing pressure to reduce in-house manufacturing costs, the rising complexity of oral solid dosage formulations, growing generic drug production volumes, limited internal manufacturing capacity of pharmaceutical companies, and an increasing reliance on third-party CMOs.

The oral solid dosage contract manufacturing market is projected to experience substantial expansion over the coming years. This market is forecast to reach $59.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. This anticipated growth is driven by several factors, including an escalating demand for scalable pharmaceutical production solutions, an expanding range of oral solid dosage drugs in development, increased investment in sophisticated manufacturing technologies, the broadening scope of pharmaceutical outsourcing in nascent markets, and a heightened requirement for agile and swift production capacities. Key trends expected during this period involve a surge in pharmaceutical companies’ outsourcing of oral solid dosage manufacturing, a greater need for large-volume and economical tablet and capsule manufacturing, the expanding use of modified and controlled-release oral solid dosage formulations, an intensified emphasis on regulatory adherence and quality assurance in contract manufacturing, and a rising inclination towards comprehensive manufacturing and packaging services.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Major Factors Are Driving The Expansion Of The Oral Solid Dosage Contract Manufacturing Market?

The future expansion of the oral solid dosage contract manufacturing market is anticipated, driven by the growing need for generic drugs. These medications mirror brand-name drugs across aspects like dosage, strength, safety, performance, quality, and their intended application. The increased appetite for generics stems from factors such as patents expiring, initiatives to control costs, encouraging regulations, and wider access to healthcare services. Oral solid dosage contract manufacturing plays a crucial role in the creation and supply of generic medicines, utilizing contract manufacturers’ expertise to boost efficiency, lower expenses, guarantee superior quality, and accelerate product launches. Illustratively, the Food and Drug Administration (FDA), a federal agency in the US, indicated that by 2025, more than 35,000 generic drugs received FDA approval, with 9 out of 10 prescriptions being for generics. Additionally, in November of 2024, the FDA issued over 800 updated Product-Specific Guidances (PSGs) for immediate-release solid oral generic drug products. Consequently, the sustained demand for generic drugs fuels the expansion of the oral solid dosage contract manufacturing market.

How Are The Various Segments Of The Oral Solid Dosage Contract Manufacturing Market Categorized?

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

Which Trends Are Impacting The Growth Of The Oral Solid Dosage Contract Manufacturing Market?

Leading firms within the oral solid dosage contract manufacturing market are prioritizing the creation of advanced solutions, like continuous manufacturing systems, to maintain their competitive edge. Such a line denotes a production setup or facility employing uninterrupted manufacturing techniques for pharmaceutical or other product fabrication. An example of this is seen in January 2023, when WuXi STA, a pharmaceutical firm based in China, unveiled its inaugural continuous manufacturing line specifically for oral solid pharmaceutical goods. This state-of-the-art facility represents a major leap forward in drug production, utilizing continuous manufacturing principles to boost the efficiency, quality, and adaptability of drug production methods. This flexibility helps optimize production schedules and minimize idle periods, thereby speeding up the provision of essential medicines to those in need.

Which Major Firms Influence Developments In The Oral Solid Dosage Contract Manufacturing Market?

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Read the full oral solid dosage contract manufacturing market report here:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Region Currently Holds The Largest Share Of The Oral Solid Dosage Contract Manufacturing Market?

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oral Solid Dosage Contract Manufacturing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company

Oral Care Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Dental Flap Surgery Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report

Mouthwash Global Market Report

https://www.thebusinessresearchcompany.com/report/mouthwash-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model